Mount Sinai Prime

New York, New York 11041

0 studies enrolling now · 8 studies all time

What they study most

Advanced Malignancies, Coronary Artery Disease, Heart Failure, Hepatitis B, Locally Advanced or Metastatic Solid Tumors, Metastatic Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Ovarian Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Solid Tumor, Ulcerative Colitis

Studies at this site

• Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors — Completed
• Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies — Completed
• INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Withdrawn before enrolling
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
• Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer — Completed
• Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects — Completed
• The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) — Completed